EV Biologics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Employees
  • 284

Employees

  • Stock Symbol
  • YECO

Stock Symbol

  • Share Price
  • $0.08
  • (As of Thursday Closing)

EV Biologics General Information

Description

EV Biologics Inc enables EV Biologics to accelerate its nanotherapeutic biomanufacturing process and producer-cell line development through Lonza's global infrastructure and deep expertise in cell and gene therapy. It has been developing nanotherapeutic-producer cells and optimizing a process for the isolation of cells from tissue and expansion of cell banks using defined cell culture conditions.

Contact Information

Formerly Known As
Yulong Eco-Materials
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1621 Central Avenue
  • Cheyenne, WY 82001
  • United States
+1 (206)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
PINX
Vertical(s)
Corporate Office
  • 1621 Central Avenue
  • Cheyenne, WY 82001
  • United States
+1 (206)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EV Biologics Stock Performance

As of 12-Jun-2025, EV Biologics’s stock price is $0.08. Its current market cap is $854K with 10.2M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.08 $0.09 $0.08 - $0.51 $854K 10.2M 1.69K

EV Biologics Financials Summary

As of 31-Dec-2017, EV Biologics has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Dec-2017 FY 2017 30-Jun-2017 FY 2016 30-Jun-2016 FY 2015 30-Jun-2015
EV 15,043 6,095 474 66,110
Revenue 9,507 42,644 46,230
EBITDA 42,748 (5,884) (46,697) 14,557
Net Income 45,209 (7,430) (53,190) 8,680
Total Assets 58,954 33,278 36,443 77,598
Total Debt 6,469 10,347 9,765 12,726
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EV Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EV Biologics‘s full profile, request access.

Request a free trial

EV Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EV Biologics FAQs

  • When was EV Biologics founded?

    EV Biologics was founded in 2011.

  • Where is EV Biologics headquartered?

    EV Biologics is headquartered in Cheyenne, WY.

  • What is the size of EV Biologics?

    EV Biologics has 284 total employees.

  • What industry is EV Biologics in?

    EV Biologics’s primary industry is Biotechnology.

  • Is EV Biologics a private or public company?

    EV Biologics is a Public company.

  • What is EV Biologics’s stock symbol?

    The ticker symbol for EV Biologics is YECO.

  • What is the current stock price of EV Biologics?

    As of 12-Jun-2025 the stock price of EV Biologics is $0.08.

  • What is the current market cap of EV Biologics?

    The current market capitalization of EV Biologics is $854K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »